The Effect of Gefitinib on Treatment Necessity and Prognosis of NSCLC Patients with Early EGFR Mutations
Author(s) -
Ruiqiang Song,
Yanbo Cheng,
Tianxi Zheng
Publication year - 2022
Publication title -
contrast media and molecular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.714
H-Index - 50
eISSN - 1555-4317
pISSN - 1555-4309
DOI - 10.1155/2022/2228744
Subject(s) - gefitinib , medicine , lung cancer , epidermal growth factor receptor , oncology , stage (stratigraphy) , cancer , biology , paleontology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom